Creating Virtual Value:A $527 Million Buyout of Angiosyn by Pfizer
Written by Kristie Prinz on Tuesday, August 15th, 2006
The event Creating Virtual Value:A $527 Million Buyout of Angiosyn by Pfizer will be held on Sept 13th at 7:00 p.m. at Wilson Sonsini Goodrich & Rosati’s offices at 950 Page Mill Road Palo Alto, CA. David Mack, a partner at Alta Partners, will discuss the successful development of Angiosyn and its sale to Pfizer. Also speaking will be Ian Edvalson, who helped broker the transaction with Pfizer
Category: Biotech Industry Events
